Hereditary hypertriglyceridemic rat: A suitable model of cardiovascular disease and metabolic syndrome?

Physiological Research

Volumn 55, Issue SUPPL. 1, 2006, Pages

  Zicha, J ^a   Pechanova O ^a,b   Cacanyiova S ^b   Cebova M ^b   Kristek, F ^b   Torok J ^b   Simko F ^c   Dobesova Z ^a   Kunes J ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c Physics and Informatics   (Slovakia)

Author keywords

Cardiovascular system; Hereditary hypertriglyceridemic rat; Hypertension; Insulin resistance; Metabolic alterations

Indexed keywords

NITRIC OXIDE SYNTHASE;

ANIMAL; DISEASE MODEL; GENETICS; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY; RAT; SHORT SURVEY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NITRIC OXIDE SYNTHASE; RATS;

EID: 33847120827     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (93)

1. ADULT TREATMENT PANEL III: Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
2. AITMAN TJ, GLAZIER AM, WALLACE CA, COOPER LD, NORSWORTHY PJ, WAHID FN, AL-MAJALI KM, TREMBLING PM, MANN CJ, SHOULDERS CC, GRAF D, ST LEZIN E, KURTZ TW, KŘEN V, PRAVENEC M, IBRAHIMI A, ABUMRAD NA, STANTON LW, SCOTT J: Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21: 76-83, 1999.
3. BADER S, SCHOLZ R, KELLERER M, TIPPMER S, RETT K, MATHAEI S, FREUND P, HARING HU: Normal insulin receptor tyrosine kinase activity and glucose transporter (GLUT4) levels in the skeletal muscle of hyperinsulinemic hypertensive rats. Diabetologia 35: 712-718, 1992.
4. BAE JH, BASSENGE E, KIM KB, KIM YN, KIM KS, LEE HJ, MOON KC, LEE MS, PARK KY, SCHWEMMER M: Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis 155: 517-523, 2001.
5. BANOS G, CARVAJAL K, CARDOSO G, ZAMORA J, FRANCO M: Vascular reactivity and effect of serum in rat model of hypertriglyceridemia and hypertension. Am J Hypertens 10: 379-388, 1997.
6. BARTUS M, LOMNICKA M, LORKOWSKA B, FRANCZYK M, KOSTOGRYS RB, PISULEWSKI PM, CHLOPICKI S: Hypertriglyceridemia but not hypercholesterolemia induces endothelial dysfunction in the rat. Pharmacol Rep 57 (Suppl): 127-137, 2005.
7. BEZNAK M, KORECKY B, THOMAS G: Regression of cardiac hypertrophies of various origin. Can J Physiol Pharmacol 47: 579-586, 1969.
8. + leak with blood pressure in recombinant inbred strains. Hypertension 20: 575-582, 1992.
9. ČAČÁNYIOVÁ S, CEBOVÁ M, KRISTEK F, KUNEŠ J, DOBEŠOVÁ Z: Changes in vascular reactivity and geometry of iliac artery in spontaneously hypertensive and hypertriglyceridemic rats. Physiol Res 54: 53P, 2005.
10. CEBOVÁ M, KRISTEK F, KUNEŠ J, DOBEŠOVÁ Z: Morphological study of thoracic aorta and carotid artery in 3 and 52 week-old SHR and HTG rats. Physiol Res 55: 11P, 2006.
11. CHEN D, WANG MW: Development and application of rodent models for type 2 diabetes. Diabetes Obesity Metab 7: 307-317, 2005.
12. DAHL LK, HEINE M, TASSINARI L: Effect of chronic excess salt ingestion. Evidence that genetic factors play an important role in the susceptibility to experimental hypertension. J Exp Med 115: 1173-1190, 1962.
13. DEVYNCK MA, KUNEŠ J, LE QUAN SANG KH, ZICHA J: Membrane microviscosity and plasma triacylglycerols in the rat. Clin Sci 94: 79-85, 1998a.
14. DEVYNCK MA, ZICHA J, KUNEŠ J: Cell membrane function, hypertriglyceridemia and hypertension. Exp Clin Cardiol 3: 162-170, 1998b.
15. 2 hybrid studies. J Hypertens 20: 945-955, 2002.
16. EL HAFIDI M, BANOS G: In vivo plasma lipid oxidation in sugar-induced rat hypertriglyceridemia and hypertension. Hypertension 30: 624-628, 1997.
17. ERLICH Y, ROSENTHAL T: Contribution of nitric oxide to the beneficial effects of enalapril in the fructose-induced hyperinsulinemic rat. Hypertension 28: 754-757, 1996.
18. FEDERSPIL G, NISOLI E, VETTOR R: A critical reflection on the definition of metabolic syndrome. Pharmacol Res 53: 449-456, 2006.
19. FERRI C, BELLINI C, DESIDERI G, DI FRANCESCO L, DE MATTIA G, SANTUCCI A, BALSANO F: Salt-sensitivity is associated with a hyperinsulinaemic and hyperglycaemic response to atrial natiuretic peptide infusion in human essential hypertension. Diabetologia 37: 308-312, 1994.
20. FÍZELOVÁ A, FÍZEL A: Cardiac hypertrophy and heart disease. J Mol Cell Cardiol 15: 264-267, 1997.
21. FUENMAYOR N, MOREIRA E, CUBEDDU LX: Salt sensitivity is associated with insulin resistance in essential hypertension. Am J Hypertens 11: 397-402, 1998.
22. GOTODA T, IZUKA Y, KATO N, OSUGA J, BIHOREAU M-T, MURAKAMI T, YAMORI Y, SHIMANO H, ISHIBASHI S, YAMADA N: Absence of CD36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat Genet 22: 226-228, 1999.
23. GUDMUNDSSON GS, SINKEY CA, CHENARD CA, STUMBO PJ, HAYNES WG: Resistance vessel endothelial function in healthy humans during transient postprandial hypertriglyceridemia. Am J Cardiol 85: 381-385, 2000.
24. KADLECOVÁ M, DOBEŠOVÁ Z, ZICHA J, KUNEŠ J: Igf 2 gene as a candidate gene for metabolic syndrome in Prague hereditary hypertriglyceridemic rats. Hypertension 42: 647, 2003.
25. KADLECOVÁ M, ČEJKA J, ZICHA J, KUNEŠ J: Does Cd36 gene play a key role in disturbed glucose and fatty acid metabolism in Prague hypertensive hypertriglyceridemic rats? Physiol Res 53: 265-271, 2004.
26. KATAKAM PV, UJHELYI MR, HOENIG ME, MILLER AW: Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol 275: R788-R792, 1998.
27. KAZDOVÁ L, ŽÁK A, VRÁNA A: Increased lipoprotein oxidability and aortic lipid peroxidation in an experimental model of insulin resistance syndrome. Ann NY Acad Sci 20: 521-525, 1997.
28. KAZDOVÁ L, DIVIŠOVÁ J, HUBOVÁ H. Effect of nitric oxide synthase inhibition on glucose utilization in an experimental model of insulin resistance. Physiol Res 50: P37, 2001.
29. KLIMEŠ I, VRÁNA A, KUNEŠ J, ŠEBÖ KOVÁ E, DOBEŠOVÁ Z, ŠTOLBA P, ZICHA J: Hereditary hypertriglyceridemic rat: a new animal model of metabolic alterations in hypertension. Blood Pressure 4: 137-142, 1995.
30. KLIMEŠ I, ZICHA J, KUNEŠ J, ŠEBOKOVÁ E: Hypertriglyceridemia, insulin resistance and hypertension in rats: are they related? Endocr Regul 31: 103-119, 1997.
31. KLIMEŠ I, WESTON K, KOVÁCS P, GAŠPERÍ KOVÁ D, JEŽOVÁ D, KVETŇANSKÝ R, THOMPSON JR, ŠEBÖKOVÁ E, SAMANI NJ: Mapping of genetic loci predisposing to hypertriglyceridaemia in the hereditary hypertriglyceridaemic rat: analysis of genetic association with related traits of the insulin resistance syndrome. Diabetologia 46: 352-358, 2003.
32. KRISTEK F, EDELSTEINOVÁ E, ŠEBOKOVÁ E, KYSELOVIČ J, KLIMEŠ I: Structural changes in the aorta of the hereditary hypertriglyceridemic rat. Ann N Y Acad Sci 827: 514-520, 1997.
33. KUNEŠ J, BIN TALIB HK, DOBEŠOVÁ Z, VRÁNA A, ZICHA J: Erythrocyte ion transport alterations in hypertriglyceridaemic rats. Clin Sci 86: 11-13, 1994.
34. KUNEŠ J, DOBEŠOVÁ Z, ZICHA J: High blood pressure of hypertriglyceridaemic rats is related to metabolic disturbances. Physiol Res 44: 421-424, 1995.
35. KUNEŠ J, MAZEAUD MM, DEVYNCK MA, ZICHA J: Platelet hypoagregability in hereditary hypertriglyceridemic rats: relation to plasma triglycerides. Thromb Res 88: 347-353, 1997.
36. KUNEŠ J, DEVYNCK MA, ZICHA J: Chronic changes in plasma triglyceride levels do modify membrane microviscosity. Life Sci 67: 959-967, 2000.
37. KUNEŠ J, DOBEŠOVÁ Z, ZICHA J: Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia. Clin Sci 102: 269-277, 2002.
38. KUNEŠ J, HOJNÁ S, KADLECOVÁ M, DOBEŠ OVÁ Z, RAUCHOVÁ H, VOKURKOVÁ M, LOUKOTOVÁ J, PECHÁŇOVÁ O, ZICHA J: Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol Res 53: S23-S34, 2004.
39. KÜNG CF, MOREAU P, TAKASE H, LÜSCHER TF: L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Hypertension 26: 744-751,1955.
40. KUSTERER K, POHL T, FORTMEYER HP, MÄRZ W, SCHARNAGL H, OLDENBUGR A, ANGERMÜLLER S, FLEMING I, USADEL KH, BUSSE R: Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilation in rats. Cardiovasc Res 42: 783-793, 1999.
41. LEWIS TV, DART AM, CHIN-DUSTING JPF: Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. J Am Coll Cardiol 33: 805-812, 1999.
42. LICHARDUS B, ŠEBÖKOVÁ E, JEŽOVÁ D, MITKOVÁ A, ZEMÁNKOVÁ A, VRÁNA A, KLIMEŠ I: Effect of low salt diet on blood pressure and vasoactive hormones in the hereditary hypertriglyceridemic rat. Ann NY Acad Sci 683: 289-294, 1993.
43. LUNDMAN P, TORNVALL P, NILSSON L, PERNOW J: A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation. Atherosclerosis 159: 35-41, 2001.
44. MCMURTHY JP, WEXLER BC: Hypersensitivity of spontaneously hypertensive rats (SHR) to heat, ether, and immobilization. Endocrinology 108: 1730-1736, 1981.
45. OGIHARA T, ASANO T, ANDO K, SAKODA H, ANAI M, SHOJIMA N, ONO H, ONISHI Y, FUJISHIRO M, ABE M, FUKUSHIMA Y, KIKUCHI M, FUJITA T: High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 40: 83-89, 2002.
46. OGIHARA T, ASANO T, FUJITA T: Contribution of salt intake to insulin resistance associated with hypertension. Life Sci 73: 509-523, 2003.
47. PECHÁŇOVÁ O, MATUŠKOVÁ J, CAPÍKOVÁ D, JENDEKOVÁ L, PAULIS ?, ŠIMKO F: Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats. Kidney Int 70: 170-176, 2006.
48. PERNOLLET MG, KUNEŠ J, ZICHA J, DEVYNCK MA: Cyclic nucleotides in platelets of genetically hypertriglyceridemic and hypertensive rats: thrombin and nitric oxide responses are unrelated to plasma triglyceride levels. Thromb Res 104: 29-37, 2001.
49. PIEPER GM, MEIER DA, HAGER SR: Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia. Am J Physiol 269: H845-H850, 1995.
50. PRAVENEC M, KLÍR P, KŘEN V, ZICHA J, KUNEŠ J: An analysis of spontaneous hypertension in spontaneously hypertensive rats by means of new recombinant inbred strains. J Hypertens 7: 217-221, 1989.
51. PRAVENEC M, LANDA V, ZÍDEK V, MUSILOVÁ A, KŘEN V, KAZDOVÁ L, AITMAN TJ, GLAZIER AM, IBRAHIMI A, ABUMRAD NA, QI N, WANG JM, ST. LEZIN EM, KURTZ TW: Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 27: 156-158, 2001.
52. PRAVENEC M, LANDA V, ZÍDEK V, MUSILOVÁ A, KAZDOVÁ L, QI N, WANG JM, ST. LEZIN EM, KURTZ TW: Transgenic expression of Cd36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol Res 52: 681-688, 2003.
53. PRAVENEC M, ZÍDEK V, LANDA V, ŠIMÁKOVÁ M, MLEJNEK P, KAZDOVÁ L, BÍLÁ V, KŘENOVÁ D, KŘEN V: Genetic analysis of "metabolic syndrome" in the spontaneously hypertensive rat. Physiol Res 53 (Suppl 1): S15-S22, 2004.
54. QI N, KAZDOVÁ L, ZÍDEK V, LANDA V, KŘEN V, PERSHADSINGH HA, ST. LEZIN EM, ABUMRAD NA, PRAVENEC M, KURTZ TW: Pharmacogenetic evidence that Cd36 is a key determinant of the metabolic effects of pioglitazone. J Biol Chem 277: 48501-48507, 2002.
55. RAINWATER DL, ALMASY L, BLANGERO J, COLE SA, VANDEBERG JL, MAC CLUER JW, HIXSON JE: A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol 19: 777-783, 1999.
56. REAVEN GM: Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
57. REAVEN GM: The metabolic syndrome: requiescat in pace. Clin Chem 51: 931-938, 2005.
58. REAVEN GM, CHANG H: Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto rats. Am J Hypertens 4: 34-38, 1991.
59. REAVEN GM, CHANG H, HOFFMAN BB, AZHAR S: Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes 38: 1155-1160, 1989.
60. REAVEN GM, TWERSKY J, CHANG H: Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension 18: 630-635, 1991.
61. REIL TD, BARNARD RJ, KASHYAP VS, ROBERTS CK, GELABERT HA: Diet-induced changes in endothelial-dependent relaxation of the rat aorta. J Surg Res 85: 96-100, 1999.
62. ROSENFELD ME, TSUKADA T, GOWN T, ROSS AM: Fatty streak initiation in Watanabe hereditable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 7: 9-23, 1987.
63. SARAFIDIS PA, NILSSON PM: The metabolic syndrome: a glance at its history. J Hypertens 24: 621-626, 2006.
64. SHARMA AM, RULAND K, SPIES KP, DISTLER A: Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 9: 329-335, 1991.
65. SHISHIDO T, TASAKI K, TAKEISHI Y, TAKASAKI S, MIYAMOTO T, ITOH M, TAKAHASHI H, KUBOTA I, ITO T, KATANO Y, WAKABAYASHI I, TOMOIKE H: Chronic hypertriglyceridemia in young Watanabe heritable hyperlipidemic rabbits impairs endothelial and medial smooth muscle function. Life Sci 74: 1487-1501, 2004.
66. ŠEBOKOVÁ E, KLIMEŠ I, MOSS R, MITKOVÁ A, WIERSMA M, BOHOV P: Decreased glucose transporter protein (GLUT4) in skeletal muscle of hypertriglyceridaemic insulin-resistant rat. Physiol Res 44: 87-92, 1995.
67. ŠEDA O, KAZDOVÁ L, KŘENOVÁ D, KŘEN V: Rosiglitazone fails to improve hypertriglyceridemia and glucose tolerance in CD36-deficient BN.SHR4 congenic rat strain. Physiol Genomics 12: 73-78, 2003.
68. ŠIMKO F: Physiologic and pathologic myocardial hypertrophy: physiologic and pathologic regression of hypertrophy? Med Hypotheses 58: 11-14, 2002.
69. ŠIMKO F, LUPTÁK I, MATUŠKOVÁ J, BABÁL P, PECHÁŇOVÁ O., BERNÁTOVÁ I., HULÍN I: Heart remodeling in the hereditary hypertriglyceridemic (hHTG) rat: effect of captopril and nitric oxide deficiency. Ann NY Acad Sci 967: 454-462, 2002.
70. ŠIMKO F, PECHÁŇOVÁ P, BERNÁTOVÁ I, PELOUCH V: Effect of angiotensin converting enzyme inhibitors on non-diseased myocardium of experimental animals: potential clinical implications. Med Hypotheses 54: 626-627, 2000.
71. ŠIMKO F, PELOUCH V, TÖRÖK J, LUPTÁK I, MATUŠKOVÁ J, PECHÁŇOVÁ O, BABÁL P: Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ACE-inhibition. J Biomed Sci 12: 103-111, 2005.
72. ŠKOTTOVÁ N, KAZDOVÁ L, OLIYARNYK O, VEČEŘA R, SOBOLOVÁ L, ULRICHOVÁ J: Phenolics-rich extracts from Silybum marianum and Prunella vulgaris reduce a high-sucrose diet induced oxidative stress in hereditary hypertriglyceridemic rats. Pharmacol Res 50: 123-130, 2004.
73. ŠTOLBA P, DOBEŠOVÁ Z, HUšEK P, OPLTOVÁ H, ZICHA J, VRÁNA A, KUNEŠ J: The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci 51: 733-740, 1992.
74. ŠTOLBA P, OPLTOVÁ H, HUŠEK P, NEDVÍ DKOVÁ J, KUNEŠ J, DOBEŠOVÁ Z, NEDVÍDEK J, VRÁNA A: Adrenergic overactivity and insulin resistance in nonobese hypertriglyceridemic rat. Ann NY Acad Sci 14: 281-288, 1993.
75. TÖRÖK J, GEROVÁ M: Developmental dynamics of endothelial and neurogenic control of canine thoracic aorta. Mech Ageing Dev 95: 143-152,1997.
76. TÖRÖK J, BABÁL P, MATUŠKOVÁ J, LUPTÁK I, KLIMEŠ I, ŠIMKO F: Impaired endothelial function of thoracic aorta in hereditary hypertriglyceridemic rats. Ann N Y Acad Sci 967: 469-475, 2002.
77. TÖRÖK J, KRISTEK F, GEROVÁ M, KUNEŠ J, DOBEŠOVÁ Z: Endothelial function of conduit artery in newborn rats with hereditary hypertriglyceridemia. Physiol Res 52: 52P, 2003a.
78. TÖRÖK J, MATUŠKOVÁ J, PECHÁŇ OVÁ O, KRAJČOVIČOVÁ K, ŠIMKO F: Simvastatin improves endothelial function of aorta in hereditary hypertriglyceridemic rats. Physiol Res 52: 43P, 2003b.
79. TÖRÖK J, KOPRDOVÁ R, CEBOVÁ M, KRISTEK F: Functional and morphological pattern of vascular responses in early stage of experimental hypertension. In: New Frontiers in Basic Cardiovascular Research, 7th Meeting of France with New EU Members, 2006, p.52.
80. UENO T, TREMBLAY J, KUNEŠ J, ZICHA J, DOBEŠOVÁ Z, PAUSOVÁ Z, DENG AY, SUN Y-L, JACOB HJ, HAMET P: Resolving the composite trait of hypertension into genetic determinants by pharmacogenetic subtraction of blood pressure regulatory system. J Mol Med 81: 51-60, 2003a.
81. UENO T, TREMBLAY J, KUNEŠ J, ZICHA J, DOBEŠOVÁ Z, PAUSOVÁ Z, DENG AY, SUN Y, JACOB HJ, HAMET P: Gender-specific genetic determinants of blood pressure and organ weight: pharmacogenetic approach. Physiol Res 52: 689-700, 2003b.
82. UENO T, TREMBLAY J, KUNEŠ J, ZICHA J, DOBEŠOVÁ Z, PAUSOVÁ Z, DENG AY, SUN YL, JACOB HJ, HAMET P: Rat model of familial combined hyperlipidemia as a result of comparative mapping. Physiol Genomics 12: 38-47, 2004.
83. VINCENT M, SACQUET J, SASSARD J: The Lyon strains of hypertensive, normotensive and low-blood-pressure rats. In: Handbook of Hypertension. Vol. 4: Experimental and Genetic Models of Hypertension, W. DE JONG (ed), Elsevier, Amsterdam, 1984, pp 314-327.
84. VRÁNA A, KAZDOVÁ L: Insulin sensitivity of rat adipose tissue and of diaphragm in vitro: effect of the type of dietary carbohydrates (starch-sucrose). Life Sci 9: 257-265, 1970.
85. VRÁNA A, KAZDOVÁ L: The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. Transpl Proc 22: 2579, 1990.
86. VRÁNA A, FÁBRY P, KAZDOVÁ L, POLEDNE R, SLABOCHOVÁ Z: Sucrose-induced hypertriglyceriaemia: its mechanism and metabolic effects. Czech Med 5: 9-15, 1982.
87. VRÁNA A, KAZDOVÁ L, DOBEŠOVÁ Z, KUNEŠ J, KŘEN V, BÍLÁ V, ŠTOLBA P, KLIMEŠ I: Triglyceridemia, glucoregulation, and blood pressure in various rat strains. Effect of carbohydrates. Ann NY Acad Sci 683: 57-68, 1993.
88. WEBER KT: Fibrosis and hypertensive heart disease. Curr Opin Cardiol 15: 264-267, 1997.
89. YAMORI Y, OHTA M, UESHIMA H, NARA Y, HORIE R, SHIMAMOTO T, KOMACHI Y: Glucose tolerance in spontaneously hypertensive rats. Jpn Circ J 42: 841-847, 1978.
90. 2 rats of HTGxLewis cross. Physiol Res 44: 425-428, 1995.
91. ZICHA J, KUNEŠ J, DAVID-DUFILHO M, PERNOLLET MG, DEVYNCK MA: Cell calcium handling and intracellular pH regulation in hereditary hypertriglyceridemic rats: reduced platelet response to thrombin stimulation. Life Sci 59: 803-813, 1996.
92. ZICHA, J, DOBEŠOVÁ Z, KUNEŠ J: Plasma triglycerides and red cell ion transport alterations in genetically hypertensive rats. Hypertension 30: 636-640, 1997.
93. ZICHA J, KUNEŠ J, DEVYNCK MA: Abnormalities of membrane function and lipid metabolism in hypertension: a review. Am J Hypertens 12: 315-331, 1999.